- Infectious Diseases Therapeutics
- cancer therapeutics
- Dermatology therapeutics
- Ophthalmology therapeutics
- Hematology Therapeutics
- Gastrointestinal therapeutics
- Women's Health therapeutics
- Dental Therapeutics
- Neurology therapeutics
- Respiratory therapeutics
- Diabetes Therapeutics
- Men's Health therapeutics
- Cardiovascular therapeutics
- Central Nervous System (CNS) therapeutics
- Urology therapeutics
- Kidney
- Sexually Transmitted Diseases Therapeutics
- Metabolic therapeutics therapeutics
- Pulmonary therapeutics
- Orthopedic therapeutics
- Arthritis therapeutics
- Oral Therapeutics
- Allergy therapeutics
- ENT Therapeutics
- Radiology therapeutics
- Hiv/Aids Therapeutics
Therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... opment, 2022, provides an overview of the B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline landscape.
B-Cell Chronic Lymphocytic Leukemia is a type of slow growing leukemia that affects developing B-lymphocytes (also known as B-ce......" | 29-Apr-2022 | $2000 | |
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... , provides an overview of the Hodgkin Lymphoma (Oncology) pipeline landscape.
Hodgkin lymphoma is a cancer that starts in white blood cells called lymphocytes. Symptoms include painless swelling of the lymph nodes in the neck, armpits, o......" | 29-Apr-2022 | $2500 | |
Polycythemia Vera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... f the Polycythemia Vera (Oncology) pipeline landscape.
Polycythemia Vera (PV) is a stem cell disorder characterized as a panhyperplastic, malignant and neoplastic marrow disorder. Symptoms include itchiness, headache, dizziness, weakness......" | 29-Apr-2022 | $2000 | |
Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... osarcoma (Oncology) pipeline landscape.
Osteosarcoma is the most common cancer of the bone that destroys tissue and weakens the bone. It is developed from immature bone cells that normally form new bone tissue. Symptoms include pain, bon......" | 29-Apr-2022 | $2500 | |
Anal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ancer (Oncology) pipeline landscape.
Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feel......" | 29-Apr-2022 | $2000 | |
Rectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ctal Cancer (Oncology) pipeline landscape.
Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon ......" | 29-Apr-2022 | $2000 | |
Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... erview of the Nasopharyngeal Cancer (Oncology) pipeline landscape.
Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of throat, behind the nose. This area is called the nasopharynx. The risk factor......" | 29-Apr-2022 | $2500 | |
Leiomyosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Leiomyosarcoma (Oncology) pipeline landscape.
Leiomyosarcoma is an aggressive soft tissue sarcoma derived from smooth muscle cells typically of uterine, gastrointestinal or soft tissue origin. Symptoms include a noticeable lump or swelli......" | 29-Apr-2022 | $2000 | |
Fibrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... osarcoma (Oncology) pipeline landscape.
Fibrosarcoma is a malignant tumor derived from fibrous connective tissue. Symptoms include local pain, local swelling, local warmth, dilated blood vessels pain and swelling of the bone, pathologica......" | 29-Apr-2022 | $2000 | |
Synovial Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... the Synovial Sarcoma (Oncology) pipeline landscape.
Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or spindle cell components. Symptoms include swelling, mass that ma......" | 29-Apr-2022 | $2000 | |
|